Automated chest compression devices are medical equipment used to perform automated external chest compression during cardiac arrest events and resuscitation. These devices provide consistent, high-quality chest compressions to patients in cardiac arrest, allowing emergency medical service personnel to focus on other life-saving interventions such as airway management and drug administration. Automated chest compression devices ensure that chest compressions are performed continuously at the correct depth and rate, minimizing interruptions. The global Automated CPR Devices Market is estimated to be valued at US$ 127.06 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising incidence of sudden cardiac arrests across the world is a key factor driving the growth of the automated CPR devices market. According to the American Heart Association, over 350,000 out-of-hospital cardiac arrests occur annually in the United States. Early and high-quality CPR provided by bystanders or emergency medical service personnel increases the chances of survival after cardiac arrest. Automated chest compression devices help in providing consistent, effective CPR to cardiac arrest patients on the scene and during transportation to hospitals. This improves clinical outcomes and boosts the survival rates of patients suffering cardiac arrests. The growing adoption of these devices by emergency medical services and hospitals is expected to propel the automated CPR devices market during the forecast period.
Segment Analysis
The global automated CPR devices market is segmented into piston driven devices and load distributing devices. The piston-driven devices segment is dominating the market owing to increasing adoption of automated chest compression systems for cardiac arrest emergencies in hospitals. Piston-driven devices use a simple mechanism to provide chest compressions through a piston that pushes against the chest automatically at regular intervals to circulate blood and oxygen in the body during cardiac arrest.
Key Takeaways
The global automated CPR devices market analysis is expected to witness high growth.
Regional analysis: North America region is dominating the automated CPR devices market owing to growing incidences of cardiac arrest cases, developed healthcare infrastructure and availability of advanced life-saving devices. The United States accounts for the largest share in the North America automated CPR devices market due to increasing adoption of automated CPR devices for emergency cardiac care in hospitals.
Key players operating in the automated CPR devices market are AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd. Companies operating in the market are focusing on new product launches and geographical expansion strategies to strengthen their market position.
Get more insights on this topic: https://www.newswirestats.com/automated-cpr-devices-market-industry-insights-trends-automated-cpr-devices-market/
Comments
0 comment